default author photo

Michelle Dickey

Cincinnati Children's Hospital Medical Center - Division of Infectious Diseases

3333 Burnet Avenue

Cincinnati, OH 45229

United States

SCHOLARLY PAPERS

3

DOWNLOADS

325

TOTAL CITATIONS

1

Scholarly Papers (3)

1.

Safety and Immunogenicity of a Nipah Virus Vaccine (Hev-Sg-V) in Adults: A Single-Centre, Randomised, Observer-Blind, Placebo-Controlled, Phase 1 Study

Number of pages: 31 Posted: 30 May 2024
Cincinnati Children's Hospital Medical Center - Division of Infectious Diseases, PATH, PATH, Cincinnati Children's Hospital Medical Center - Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center - Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center - Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center - Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center - Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center - Division of Infectious Diseases, Auro Vaccines LLC, Cincinnati Children's Hospital Medical Center - Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center - Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center - Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center - Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center - Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center - Division of Infectious Diseases, PATH, PATH, PATH, PATH, PATH, PATH, PATH and PATH
Downloads 161 (464,454)
Citation 1

Abstract:

Loading...

Nipah virus, vaccine, randomised clinical trial, infectious diseases

2.

Efficacy, Safety, and Immunogenicity of the Shigella sonnei 1790GAHB GMMA Candidate Vaccine: Results from a Phase 2b Randomized, Placebo-Controlled Challenge Study in Adults

Number of pages: 33 Posted: 02 Mar 2021
Cincinnati Children's Hospital Medical Center - Division of Infectious Diseases, GSK Vaccines Institute for Global Health, GSK Vaccines Institute for Global Health, GSK Vaccines Institute for Global Health, Cincinnati Children's Hospital Medical Center - Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center - Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center - Division of Infectious Diseases, GSK Vaccines Institute for Global Health, GSK, GSK, GSK Vaccines Institute for Global Health, Walter Reed Army Institute of Research - Department of Diarrheal Disease Research, Bacterial Diseases Branch, GSK Vaccines Institute for Global Health, GSK Vaccines Institute for Global Health, Walter Reed Army Institute of Research - Department of Diarrheal Disease Research, Bacterial Diseases Branch, Walter Reed Army Institute of Research - Department of Diarrheal Disease Research, Bacterial Diseases Branch, GSK Vaccines Institute for Global Health, GSK Vaccines Institute for Global Health, Walter Reed Army Institute of Research - Department of Diarrheal Disease Research, Bacterial Diseases Branch, GSK Vaccines Institute for Global Health, Fondazione Toscana Life Sciences - Monoclonal Antibody Discovery Lab (MAD), Burnet Institute, GSK Vaccines Institute for Global Health and GSK Vaccines Institute for Global Health
Downloads 122 (588,531)

Abstract:

Loading...

Shigella sonnei, 1790GAHB vaccine, GMMA, human challenge study, controlled human infection model, shigellosis

3.

Efficacy of WRSs2, a Live-Attenuated Shigella sonnei Vaccine, Against Shigellosis in a Controlled Human Infection Model: A Double-Blind, Randomized Trial

Number of pages: 27 Posted: 02 Mar 2026
Emory University, Government of the United States of America - National Institute of Allergy and Infectious Diseases (NIAID), Cincinnati Children's Hospital Medical Center - Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center - Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center - Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center - Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center - Division of Infectious Diseases, Emory University, Emory University, Emory University, Emory University, The Emmes Company, The Emmes Company, The Emmes Company, Government of the United States of America - National Institute of Allergy and Infectious Diseases (NIAID), Government of the United States of America - National Institute of Allergy and Infectious Diseases (NIAID), Walter Reed Army Institute of Research, Walter Reed Army Institute of Research, United States Department of the Navy - Naval Medical Research Center - Silver Spring, Walter Reed Army Institute of Research, Walter Reed Army Institute of Research, Cincinnati Children's Hospital Medical Center - Division of Infectious Diseases and Independent
Downloads 42 (1,183,237)

Abstract:

Loading...

Shigella, WRSs2 vaccine, efficacy, controlled human infection model, randomized controlled trial